Page last updated: 2024-11-05

tolperisone and Myofascial Trigger Point Pain

tolperisone has been researched along with Myofascial Trigger Point Pain in 5 studies

Tolperisone: A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)

Research Excerpts

ExcerptRelevanceReference
"To evaluate the efficacy of tolperisone (calmirex) in patients with chronic nonspecific pelvic pain receiving standard therapy."3.96[The use of myorelaxants in the treatment of chronic non-specific pelvic pain]. ( Barulin, AE; Kalinchenko, BM; Kurushina, OV, 2020)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Barulin, AE2
Kurushina, OV2
Kalinchenko, BM2
Devlikamova, FI1
Shirokov, VA1
Iun, OP1
Bakhtereva, EV1
Parfenov, VA1
Batysheva, TT1

Trials

1 trial available for tolperisone and Myofascial Trigger Point Pain

ArticleYear
[Efficiency local injection therapy with preparation mydocalm in myofascial pain syndrome cervicobrachial region].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:6

    Topics: Brachial Plexus; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Injections, Intramuscu

2009

Other Studies

4 other studies available for tolperisone and Myofascial Trigger Point Pain

ArticleYear
[Efficiency of the application of miorelaxants in lower cross myofascial syndrome].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:9

    Topics: Female; Humans; Male; Myofascial Pain Syndromes; Surveys and Questionnaires; Tolperisone

2021
[The use of myorelaxants in the treatment of chronic non-specific pelvic pain].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2020, Volume: 120, Issue:6

    Topics: Chronic Pain; Humans; Myofascial Pain Syndromes; Pelvic Pain; Tolperisone

2020
Results of the post-registration clinical study "PARUS" on efficiency and safety assessment of Mydocalm-Richter for local injection therapy of a myofascial trigger zone.
    Terapevticheskii arkhiv, 2018, Jun-20, Volume: 90, Issue:6

    Topics: Adult; Humans; Injections, Intramuscular; Middle Aged; Muscle Relaxants, Central; Muscle, Skeletal;

2018
[Spinal pain and its treatment with midocalm].
    Terapevticheskii arkhiv, 2003, Volume: 75, Issue:5

    Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Middle Aged; Muscle Relaxants, C

2003